Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Clin Cases. Jul 6, 2021; 9(19): 5126-5134
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5126
Table 1 Baseline demographics and characteristics

ESPB group (n = 30)
Control group (n = 29)
P value
Sex (Male/Female)13/178/210.207
Age, yr61 ± 1264 ± 100.364
Height, cm165 ± 9163 ± 80.284
Weight, kg70 ± 966 ± 90.146
ASA (I/II/III)11/16/36/17/60.283
Preoperative resting NRS4 (3-5)4 (3-5)0.871
Preoperative moving NRS6 (5-7)5 (4-7)0.195
Surgery segment
T121 (3.3)2 (6.9)0.557
L12 (6.7)3 (10.3)0.643
L25 (16.7)8 (27.6)0.351
L317 (56.7)24 (82.8)0.054
L427 (90.0)28 (96.6)0.643
L528 (93.3)28 (96.6)1.000
S114 (46.7)13 (44.8)0.797
Table 2 Intraoperative variables

ESPB group (n = 30)
Control group (n = 29)
P value
Duration of anesthesia, min193 ± 56205 ± 540.242
Dose of sufentanil, ug20 ± 625 ± 60.003
Dose of cisatracurium, mg31 ± 1241 ± 100.001
MOAA/S at extubation4.1 ± 0.53.3 ± 0.60.000
MOAA/S 10 min after extubation4.5 ± 0.54.0 ± 0.50.001
MOAA/S 20 min after extubation4.9 ± 0.34.4 ± 0.60.000
MOAA/S 30 min after extubation5.0 ± 0.04.9 ± 0.40.073
Duration in the PACU, min35 ± 244 ± 150.001
Table 3 Postoperative variables

ESPB group (n = 30)
Control group (n = 29)
P value
Duration to the first PCIA bolus, h8.0 (4.5-17.0)1 (0.5-6)0.000
Resting NRS 24 h post operation1 (1-2)2 (1-3)0.084
Coughing NRS 24 h post operation3 (2-4)3 (2-5)0.075
Resting NRS 48 h post operation1 (0-1)1 (1-2)0.012
Coughing NRS 48 h post operation2 (1-2)3 (2-4)0.002
Morphine consumption 24 h post operation, mg18 (14-24)18 (14-28)0.339
Morphine consumption 48 h post operation, mg36 (28-45)36 (33-55)0.120
Time to first ambulation, hour95 (72-96)96 (76-114)0.024
Resting NRS on postoperative 30th d1 (0-1)2 (1-2)0.001